Selected research
Industry Research
Cystic Fibrosis Drugs Industry Research Report 2026
Market perspective
The global Cystic Fibrosis Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cystic Fibrosis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cystic Fibrosis Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cystic Fibrosis Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cystic Fibrosis Drugs include Abbott, Johnson & Johnson, Novartis, Vertex Pharmaceuticals, Venus Remedies, United Medical, PTC Therapeutics, Proteostasis Therapeutics and Pharmaxis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cystic Fibrosis Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cystic Fibrosis Drugs Market by Company
Abbott
Johnson & Johnson
Novartis
Vertex Pharmaceuticals
Venus Remedies
United Medical
PTC Therapeutics
Proteostasis Therapeutics
Pharmaxis
PharmaSwiss
Novo Nordisk
Neovii Biotech
Merck Sharp & Dohme
Insmed
Gilead Sciences
Genzyme
F. Hoffmann-La Roche
Corbus Pharmaceuticals
Chiesi Farmaceutici
Boehringer Ingelheim
Arcturus Therapeutics
Anthera Pharmaceuticals
Actavis
Cystic Fibrosis Drugs Segment by Type
Oral Cystic Fibrosis Drugs
Injection Cystic Fibrosis Drugs
Cystic Fibrosis Drugs Segment by Application
Hospitals
Clinics
Other
Cystic Fibrosis Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cystic Fibrosis Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cystic Fibrosis Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cystic Fibrosis Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cystic Fibrosis Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cystic Fibrosis Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cystic Fibrosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Cystic Fibrosis Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Cystic Fibrosis Drugs Sales (K Units) of Manufacturers (2021-2026)
Table 7. Global Cystic Fibrosis Drugs Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Cystic Fibrosis Drugs Revenue of Manufacturers (2021-2026)
Table 9. Global Cystic Fibrosis Drugs Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Cystic Fibrosis Drugs Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Cystic Fibrosis Drugs Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Cystic Fibrosis Drugs, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Cystic Fibrosis Drugs, Product Type & Application
Table 14. Global Cystic Fibrosis Drugs Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Cystic Fibrosis Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Abbott Company Information
Table 19. Abbott Business Overview
Table 20. Abbott Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. Abbott Cystic Fibrosis Drugs Product Portfolio
Table 22. Abbott Recent Developments
Table 23. Johnson & Johnson Company Information
Table 24. Johnson & Johnson Business Overview
Table 25. Johnson & Johnson Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Johnson & Johnson Cystic Fibrosis Drugs Product Portfolio
Table 27. Johnson & Johnson Recent Developments
Table 28. Novartis Company Information
Table 29. Novartis Business Overview
Table 30. Novartis Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. Novartis Cystic Fibrosis Drugs Product Portfolio
Table 32. Novartis Recent Developments
Table 33. Vertex Pharmaceuticals Company Information
Table 34. Vertex Pharmaceuticals Business Overview
Table 35. Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
Table 37. Vertex Pharmaceuticals Recent Developments
Table 38. Venus Remedies Company Information
Table 39. Venus Remedies Business Overview
Table 40. Venus Remedies Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Venus Remedies Cystic Fibrosis Drugs Product Portfolio
Table 42. Venus Remedies Recent Developments
Table 43. United Medical Company Information
Table 44. United Medical Business Overview
Table 45. United Medical Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. United Medical Cystic Fibrosis Drugs Product Portfolio
Table 47. United Medical Recent Developments
Table 48. PTC Therapeutics Company Information
Table 49. PTC Therapeutics Business Overview
Table 50. PTC Therapeutics Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. PTC Therapeutics Cystic Fibrosis Drugs Product Portfolio
Table 52. PTC Therapeutics Recent Developments
Table 53. Proteostasis Therapeutics Company Information
Table 54. Proteostasis Therapeutics Business Overview
Table 55. Proteostasis Therapeutics Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. Proteostasis Therapeutics Cystic Fibrosis Drugs Product Portfolio
Table 57. Proteostasis Therapeutics Recent Developments
Table 58. Pharmaxis Company Information
Table 59. Pharmaxis Business Overview
Table 60. Pharmaxis Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. Pharmaxis Cystic Fibrosis Drugs Product Portfolio
Table 62. Pharmaxis Recent Developments
Table 63. PharmaSwiss Company Information
Table 64. PharmaSwiss Business Overview
Table 65. PharmaSwiss Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. PharmaSwiss Cystic Fibrosis Drugs Product Portfolio
Table 67. PharmaSwiss Recent Developments
Table 68. Novo Nordisk Company Information
Table 69. Novo Nordisk Business Overview
Table 70. Novo Nordisk Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Novo Nordisk Cystic Fibrosis Drugs Product Portfolio
Table 72. Novo Nordisk Recent Developments
Table 73. Neovii Biotech Company Information
Table 74. Neovii Biotech Business Overview
Table 75. Neovii Biotech Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Neovii Biotech Cystic Fibrosis Drugs Product Portfolio
Table 77. Neovii Biotech Recent Developments
Table 78. Merck Sharp & Dohme Company Information
Table 79. Merck Sharp & Dohme Business Overview
Table 80. Merck Sharp & Dohme Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Merck Sharp & Dohme Cystic Fibrosis Drugs Product Portfolio
Table 82. Merck Sharp & Dohme Recent Developments
Table 83. Insmed Company Information
Table 84. Insmed Business Overview
Table 85. Insmed Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Insmed Cystic Fibrosis Drugs Product Portfolio
Table 87. Insmed Recent Developments
Table 88. Gilead Sciences Company Information
Table 89. Gilead Sciences Business Overview
Table 90. Gilead Sciences Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Gilead Sciences Cystic Fibrosis Drugs Product Portfolio
Table 92. Gilead Sciences Recent Developments
Table 93. Genzyme Company Information
Table 94. Genzyme Business Overview
Table 95. Genzyme Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Genzyme Cystic Fibrosis Drugs Product Portfolio
Table 97. Genzyme Recent Developments
Table 98. F. Hoffmann-La Roche Company Information
Table 99. F. Hoffmann-La Roche Business Overview
Table 100. F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Portfolio
Table 102. F. Hoffmann-La Roche Recent Developments
Table 103. Corbus Pharmaceuticals Company Information
Table 104. Corbus Pharmaceuticals Business Overview
Table 105. Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
Table 107. Corbus Pharmaceuticals Recent Developments
Table 108. Chiesi Farmaceutici Company Information
Table 109. Chiesi Farmaceutici Business Overview
Table 110. Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Chiesi Farmaceutici Cystic Fibrosis Drugs Product Portfolio
Table 112. Chiesi Farmaceutici Recent Developments
Table 113. Boehringer Ingelheim Company Information
Table 114. Boehringer Ingelheim Business Overview
Table 115. Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Boehringer Ingelheim Cystic Fibrosis Drugs Product Portfolio
Table 117. Boehringer Ingelheim Recent Developments
Table 118. Arcturus Therapeutics Company Information
Table 119. Arcturus Therapeutics Business Overview
Table 120. Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Arcturus Therapeutics Cystic Fibrosis Drugs Product Portfolio
Table 122. Arcturus Therapeutics Recent Developments
Table 123. Anthera Pharmaceuticals Company Information
Table 124. Anthera Pharmaceuticals Business Overview
Table 125. Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
Table 127. Anthera Pharmaceuticals Recent Developments
Table 128. Actavis Company Information
Table 129. Actavis Business Overview
Table 130. Actavis Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Actavis Cystic Fibrosis Drugs Product Portfolio
Table 132. Actavis Recent Developments
Table 133. Global Cystic Fibrosis Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 134. Global Cystic Fibrosis Drugs Sales by Region (2021-2026) & (K Units)
Table 135. Global Cystic Fibrosis Drugs Sales Market Share by Region (2021-2026)
Table 136. Global Cystic Fibrosis Drugs Sales by Region (2027-2032) & (K Units)
Table 137. Global Cystic Fibrosis Drugs Sales Market Share by Region (2027-2032)
Table 138. Global Cystic Fibrosis Drugs Revenue by Region (2021-2026) & (US$ Million)
Table 139. Global Cystic Fibrosis Drugs Revenue Market Share by Region (2021-2026)
Table 140. Global Cystic Fibrosis Drugs Revenue by Region (2027-2032) & (US$ Million)
Table 141. Global Cystic Fibrosis Drugs Revenue Market Share by Region (2027-2032)
Table 142. North America Cystic Fibrosis Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 143. North America Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 144. North America Cystic Fibrosis Drugs Sales by Country (2027-2032) & (K Units)
Table 145. North America Cystic Fibrosis Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 146. North America Cystic Fibrosis Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 147. Europe Cystic Fibrosis Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 148. Europe Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 149. Europe Cystic Fibrosis Drugs Sales by Country (2027-2032) & (K Units)
Table 150. Europe Cystic Fibrosis Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 151. Europe Cystic Fibrosis Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 152. Asia Pacific Cystic Fibrosis Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 153. Asia Pacific Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 154. Asia Pacific Cystic Fibrosis Drugs Sales by Country (2027-2032) & (K Units)
Table 155. Asia Pacific Cystic Fibrosis Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 156. Asia Pacific Cystic Fibrosis Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 157. South America Cystic Fibrosis Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 158. South America Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 159. South America Cystic Fibrosis Drugs Sales by Country (2027-2032) & (K Units)
Table 160. South America Cystic Fibrosis Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 161. South America Cystic Fibrosis Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 162. Middle East and Africa Cystic Fibrosis Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 163. Middle East and Africa Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 164. Middle East and Africa Cystic Fibrosis Drugs Sales by Country (2027-2032) & (K Units)
Table 165. Middle East and Africa Cystic Fibrosis Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 166. Middle East and Africa Cystic Fibrosis Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 167. Global Cystic Fibrosis Drugs Sales by Type (2021-2026) & (K Units)
Table 168. Global Cystic Fibrosis Drugs Sales by Type (2027-2032) & (K Units)
Table 169. Global Cystic Fibrosis Drugs Sales Market Share by Type (2021-2026)
Table 170. Global Cystic Fibrosis Drugs Sales Market Share by Type (2027-2032)
Table 171. Global Cystic Fibrosis Drugs Revenue by Type (2021-2026) & (US$ Million)
Table 172. Global Cystic Fibrosis Drugs Revenue by Type (2027-2032) & (US$ Million)
Table 173. Global Cystic Fibrosis Drugs Revenue Market Share by Type (2021-2026)
Table 174. Global Cystic Fibrosis Drugs Revenue Market Share by Type (2027-2032)
Table 175. Global Cystic Fibrosis Drugs Price by Type (2021-2026) & (US$/Unit)
Table 176. Global Cystic Fibrosis Drugs Price by Type (2027-2032) & (US$/Unit)
Table 177. Global Cystic Fibrosis Drugs Sales by Application (2021-2026) & (K Units)
Table 178. Global Cystic Fibrosis Drugs Sales by Application (2027-2032) & (K Units)
Table 179. Global Cystic Fibrosis Drugs Sales Market Share by Application (2021-2026)
Table 180. Global Cystic Fibrosis Drugs Sales Market Share by Application (2027-2032)
Table 181. Global Cystic Fibrosis Drugs Revenue by Application (2021-2026) & (US$ Million)
Table 182. Global Cystic Fibrosis Drugs Revenue by Application (2027-2032) & (US$ Million)
Table 183. Global Cystic Fibrosis Drugs Revenue Market Share by Application (2021-2026)
Table 184. Global Cystic Fibrosis Drugs Revenue Market Share by Application (2027-2032)
Table 185. Global Cystic Fibrosis Drugs Price by Application (2021-2026) & (US$/Unit)
Table 186. Global Cystic Fibrosis Drugs Price by Application (2027-2032) & (US$/Unit)
Table 187. Key Raw Materials
Table 188. Raw Materials Key Suppliers
Table 189. Cystic Fibrosis Drugs Distributors List
Table 190. Cystic Fibrosis Drugs Customers List
Table 191. Cystic Fibrosis Drugs Industry Trends
Table 192. Cystic Fibrosis Drugs Industry Drivers
Table 193. Cystic Fibrosis Drugs Industry Restraints
Table 194. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Cystic Fibrosis Drugs Product Image
Figure 5. Global Cystic Fibrosis Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Cystic Fibrosis Drugs Market Size (2021-2032) & (US$ Million)
Figure 7. Global Cystic Fibrosis Drugs Sales (2021-2032) & (K Units)
Figure 8. Global Cystic Fibrosis Drugs Average Price (US$/Unit) & (2021-2032)
Figure 9. Oral Cystic Fibrosis Drugs Product Image
Figure 10. Injection Cystic Fibrosis Drugs Product Image
Figure 11. Hospitals Product Image
Figure 12. Clinics Product Image
Figure 13. Other Product Image
Figure 14. Global Cystic Fibrosis Drugs Revenue Share by Manufacturers in 2025
Figure 15. Global Manufacturers of Cystic Fibrosis Drugs, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Cystic Fibrosis Drugs Players Market Share by Revenue in 2025
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Cystic Fibrosis Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 19. Global Cystic Fibrosis Drugs Sales by Region in 2025
Figure 20. Global Cystic Fibrosis Drugs Revenue by Region in 2025
Figure 21. North America Cystic Fibrosis Drugs Market Size by Country in 2025
Figure 22. North America Cystic Fibrosis Drugs Sales Market Share by Country (2021-2032)
Figure 23. North America Cystic Fibrosis Drugs Revenue Market Share by Country (2021-2032)
Figure 24. United States Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Canada Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Europe Cystic Fibrosis Drugs Market Size by Country in 2025
Figure 27. Europe Cystic Fibrosis Drugs Sales Market Share by Country (2021-2032)
Figure 28. Europe Cystic Fibrosis Drugs Revenue Market Share by Country (2021-2032)
Figure 29. Germany Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. France Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. U.K. Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Italy Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Netherlands Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Nordic Countries Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Asia Pacific Cystic Fibrosis Drugs Market Size by Country in 2025
Figure 36. Asia Pacific Cystic Fibrosis Drugs Sales Market Share by Country (2021-2032)
Figure 37. Asia Pacific Cystic Fibrosis Drugs Revenue Market Share by Country (2021-2032)
Figure 38. China Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Japan Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. South Korea Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. India Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Australia Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. China Taiwan Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Southeast Asia Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Southeast Asia Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South America Cystic Fibrosis Drugs Market Size by Country in 2025
Figure 47. South America Cystic Fibrosis Drugs Sales Market Share by Country (2021-2032)
Figure 48. South America Cystic Fibrosis Drugs Revenue Market Share by Country (2021-2032)
Figure 49. Mexico Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Brazil Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Argentina Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Colombia Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. Middle East and Africa Cystic Fibrosis Drugs Market Size by Country in 2025
Figure 54. Middle East and Africa Cystic Fibrosis Drugs Sales Market Share by Country (2021-2032)
Figure 55. Middle East and Africa Cystic Fibrosis Drugs Revenue Market Share by Country (2021-2032)
Figure 56. Turkey Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Saudi Arabia Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. UAE Cystic Fibrosis Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Global Cystic Fibrosis Drugs Sales Market Share by Type (2021-2032)
Figure 60. Global Cystic Fibrosis Drugs Revenue Market Share by Type (2021-2032)
Figure 61. Global Cystic Fibrosis Drugs Price (US$/Unit) by Type (2021-2032)
Figure 62. Global Cystic Fibrosis Drugs Sales Market Share by Application (2021-2032)
Figure 63. Global Cystic Fibrosis Drugs Revenue Market Share by Application (2021-2032)
Figure 64. Global Cystic Fibrosis Drugs Price (US$/Unit) by Application (2021-2032)
Figure 65. Cystic Fibrosis Drugs Value Chain
Figure 66. Cystic Fibrosis Drugs Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Cystic Fibrosis Drugs Industry Opportunities and Challenges
Scope & coverage.
Types
- Oral Cystic Fibrosis Drugs
- Injection Cystic Fibrosis Drugs
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Abbott
- Johnson & Johnson
- Novartis
- Vertex Pharmaceuticals
- Venus Remedies
- United Medical
- PTC Therapeutics
- Proteostasis Therapeutics
- Pharmaxis
- PharmaSwiss
- Novo Nordisk
- Neovii Biotech
- Merck Sharp & Dohme
- Insmed
- Gilead Sciences
- Genzyme
- F. Hoffmann-La Roche
- Corbus Pharmaceuticals
- Chiesi Farmaceutici
- Boehringer Ingelheim
- Arcturus Therapeutics
- Anthera Pharmaceuticals
- Actavis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cystic Fibrosis Drugs Market Size (2021-2032)
- 2.2.2 Global Cystic Fibrosis Drugs Sales (2021-2032)
- 2.2.3 Global Cystic Fibrosis Drugs Market Average Price (2021-2032)
- 2.3 Cystic Fibrosis Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral Cystic Fibrosis Drugs
- 2.3.3 Injection Cystic Fibrosis Drugs
- 2.4 Cystic Fibrosis Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cystic Fibrosis Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cystic Fibrosis Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Cystic Fibrosis Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Cystic Fibrosis Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Cystic Fibrosis Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cystic Fibrosis Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cystic Fibrosis Drugs, Product Type & Application
- 3.8 Global Manufacturers of Cystic Fibrosis Drugs, Established Date
- 3.9 Global Cystic Fibrosis Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Cystic Fibrosis Drugs Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Cystic Fibrosis Drugs Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Cystic Fibrosis Drugs Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Vertex Pharmaceuticals
- 4.4.1 Vertex Pharmaceuticals Company Information
- 4.4.2 Vertex Pharmaceuticals Business Overview
- 4.4.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
- 4.4.5 Vertex Pharmaceuticals Recent Developments
- 4.5 Venus Remedies
- 4.5.1 Venus Remedies Company Information
- 4.5.2 Venus Remedies Business Overview
- 4.5.3 Venus Remedies Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Venus Remedies Cystic Fibrosis Drugs Product Portfolio
- 4.5.5 Venus Remedies Recent Developments
- 4.6 United Medical
- 4.6.1 United Medical Company Information
- 4.6.2 United Medical Business Overview
- 4.6.3 United Medical Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 United Medical Cystic Fibrosis Drugs Product Portfolio
- 4.6.5 United Medical Recent Developments
- 4.7 PTC Therapeutics
- 4.7.1 PTC Therapeutics Company Information
- 4.7.2 PTC Therapeutics Business Overview
- 4.7.3 PTC Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 PTC Therapeutics Cystic Fibrosis Drugs Product Portfolio
- 4.7.5 PTC Therapeutics Recent Developments
- 4.8 Proteostasis Therapeutics
- 4.8.1 Proteostasis Therapeutics Company Information
- 4.8.2 Proteostasis Therapeutics Business Overview
- 4.8.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Portfolio
- 4.8.5 Proteostasis Therapeutics Recent Developments
- 4.9 Pharmaxis
- 4.9.1 Pharmaxis Company Information
- 4.9.2 Pharmaxis Business Overview
- 4.9.3 Pharmaxis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pharmaxis Cystic Fibrosis Drugs Product Portfolio
- 4.9.5 Pharmaxis Recent Developments
- 4.10 PharmaSwiss
- 4.10.1 PharmaSwiss Company Information
- 4.10.2 PharmaSwiss Business Overview
- 4.10.3 PharmaSwiss Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 PharmaSwiss Cystic Fibrosis Drugs Product Portfolio
- 4.10.5 PharmaSwiss Recent Developments
- 4.11 Novo Nordisk
- 4.11.1 Novo Nordisk Company Information
- 4.11.2 Novo Nordisk Business Overview
- 4.11.3 Novo Nordisk Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Novo Nordisk Cystic Fibrosis Drugs Product Portfolio
- 4.11.5 Novo Nordisk Recent Developments
- 4.12 Neovii Biotech
- 4.12.1 Neovii Biotech Company Information
- 4.12.2 Neovii Biotech Business Overview
- 4.12.3 Neovii Biotech Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Neovii Biotech Cystic Fibrosis Drugs Product Portfolio
- 4.12.5 Neovii Biotech Recent Developments
- 4.13 Merck Sharp & Dohme
- 4.13.1 Merck Sharp & Dohme Company Information
- 4.13.2 Merck Sharp & Dohme Business Overview
- 4.13.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Portfolio
- 4.13.5 Merck Sharp & Dohme Recent Developments
- 4.14 Insmed
- 4.14.1 Insmed Company Information
- 4.14.2 Insmed Business Overview
- 4.14.3 Insmed Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Insmed Cystic Fibrosis Drugs Product Portfolio
- 4.14.5 Insmed Recent Developments
- 4.15 Gilead Sciences
- 4.15.1 Gilead Sciences Company Information
- 4.15.2 Gilead Sciences Business Overview
- 4.15.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Gilead Sciences Cystic Fibrosis Drugs Product Portfolio
- 4.15.5 Gilead Sciences Recent Developments
- 4.16 Genzyme
- 4.16.1 Genzyme Company Information
- 4.16.2 Genzyme Business Overview
- 4.16.3 Genzyme Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Genzyme Cystic Fibrosis Drugs Product Portfolio
- 4.16.5 Genzyme Recent Developments
- 4.17 F. Hoffmann-La Roche
- 4.17.1 F. Hoffmann-La Roche Company Information
- 4.17.2 F. Hoffmann-La Roche Business Overview
- 4.17.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Portfolio
- 4.17.5 F. Hoffmann-La Roche Recent Developments
- 4.18 Corbus Pharmaceuticals
- 4.18.1 Corbus Pharmaceuticals Company Information
- 4.18.2 Corbus Pharmaceuticals Business Overview
- 4.18.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
- 4.18.5 Corbus Pharmaceuticals Recent Developments
- 4.19 Chiesi Farmaceutici
- 4.19.1 Chiesi Farmaceutici Company Information
- 4.19.2 Chiesi Farmaceutici Business Overview
- 4.19.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Portfolio
- 4.19.5 Chiesi Farmaceutici Recent Developments
- 4.20 Boehringer Ingelheim
- 4.20.1 Boehringer Ingelheim Company Information
- 4.20.2 Boehringer Ingelheim Business Overview
- 4.20.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Boehringer Ingelheim Cystic Fibrosis Drugs Product Portfolio
- 4.20.5 Boehringer Ingelheim Recent Developments
- 4.21 Arcturus Therapeutics
- 4.21.1 Arcturus Therapeutics Company Information
- 4.21.2 Arcturus Therapeutics Business Overview
- 4.21.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Arcturus Therapeutics Cystic Fibrosis Drugs Product Portfolio
- 4.21.5 Arcturus Therapeutics Recent Developments
- 4.22 Anthera Pharmaceuticals
- 4.22.1 Anthera Pharmaceuticals Company Information
- 4.22.2 Anthera Pharmaceuticals Business Overview
- 4.22.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.22.4 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
- 4.22.5 Anthera Pharmaceuticals Recent Developments
- 4.23 Actavis
- 4.23.1 Actavis Company Information
- 4.23.2 Actavis Business Overview
- 4.23.3 Actavis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.23.4 Actavis Cystic Fibrosis Drugs Product Portfolio
- 4.23.5 Actavis Recent Developments
5 Global Cystic Fibrosis Drugs Market Scenario by Region
- 5.1 Global Cystic Fibrosis Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cystic Fibrosis Drugs Sales by Region: 2021-2032
- 5.2.1 Global Cystic Fibrosis Drugs Sales by Region: 2021-2026
- 5.2.2 Global Cystic Fibrosis Drugs Sales by Region: 2027-2032
- 5.3 Global Cystic Fibrosis Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Cystic Fibrosis Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Cystic Fibrosis Drugs Revenue by Region: 2027-2032
- 5.4 North America Cystic Fibrosis Drugs Market Facts & Figures by Country
- 5.4.1 North America Cystic Fibrosis Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cystic Fibrosis Drugs Sales by Country (2021-2032)
- 5.4.3 North America Cystic Fibrosis Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Cystic Fibrosis Drugs Market Facts & Figures by Country
- 5.5.1 Europe Cystic Fibrosis Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cystic Fibrosis Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Cystic Fibrosis Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Cystic Fibrosis Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cystic Fibrosis Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cystic Fibrosis Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cystic Fibrosis Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cystic Fibrosis Drugs Market Facts & Figures by Country
- 5.7.1 South America Cystic Fibrosis Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cystic Fibrosis Drugs Sales by Country (2021-2032)
- 5.7.3 South America Cystic Fibrosis Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Cystic Fibrosis Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cystic Fibrosis Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cystic Fibrosis Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cystic Fibrosis Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Cystic Fibrosis Drugs Sales by Type (2021-2032)
- 6.1.1 Global Cystic Fibrosis Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Cystic Fibrosis Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Cystic Fibrosis Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Cystic Fibrosis Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cystic Fibrosis Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Cystic Fibrosis Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cystic Fibrosis Drugs Sales by Application (2021-2032)
- 7.1.1 Global Cystic Fibrosis Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Cystic Fibrosis Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Cystic Fibrosis Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Cystic Fibrosis Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cystic Fibrosis Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Cystic Fibrosis Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cystic Fibrosis Drugs Value Chain Analysis
- 8.1.1 Cystic Fibrosis Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cystic Fibrosis Drugs Production Mode & Process
- 8.2 Cystic Fibrosis Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cystic Fibrosis Drugs Distributors
- 8.2.3 Cystic Fibrosis Drugs Customers
9 Global Cystic Fibrosis Drugs Analyzing Market Dynamics
- 9.1 Cystic Fibrosis Drugs Industry Trends
- 9.2 Cystic Fibrosis Drugs Industry Drivers
- 9.3 Cystic Fibrosis Drugs Industry Opportunities and Challenges
- 9.4 Cystic Fibrosis Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst